Premedication With Intranasal Dexmedetomidine in Sedation of Patients Undergoing Total Knee Arthroplasty
Status:
Not yet recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This study aims to find out if preoperatively given dexmedetomidine is effective analgesic
adjuvant for treating postoperative pain in patients undergoing elective total knee
arthroplasty (TKA). Another aim is to determine if premedication with intranasal
dexmedetomidine could provide sufficient sedation to alleviate anxiety during TKA.